US Patent 11161798 4-hydroxybutyric acid analogs
Patent 11161798 was granted and assigned to Concert Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+465 characters)
Article
Patent abstract
This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Roger D. Tung0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111617980
Date of Patent
November 2, 2021
0Patent Application Number
202001100
Date Filed
January 10, 2020
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11161798 4-hydroxybutyric acid analogs
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11161798
Date of patent
November 2, 2021
Patent application number
20200110
Date Filed
January 10, 2020
Find more entities like US Patent 11161798 4-hydroxybutyric acid analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
